Exact Sciences
EXAS
#1544
Rank
A$17.56 B
Marketcap
$94.90
Share price
5.86%
Change (1 day)
-12.20%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total assets

Total assets on the balance sheet as of September 2024 : A$10.78 Billion

According to Exact Sciences's latest financial reports the company's total assets are A$10.78 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exact Sciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31A$9.49 B3.8%
2022-12-31A$9.15 B-0.76%
2021-12-31A$9.22 B43.96%
2020-12-31A$6.40 B27.92%
2019-12-31A$5.00 B131.46%
2018-12-31A$2.16 B182.17%
2017-12-31A$0.76 B46.58%
2016-12-31A$0.52 B4.68%
2015-12-31A$0.49 B30.73%
2014-12-31A$0.38 B132.53%
2013-12-31A$0.16 B52.36%
2012-12-31A$0.10 B14.1%
2011-12-31A$94.55 M-0.48%
2010-12-31A$95.01 M231.21%
2009-12-31A$28.68 M243.16%
2008-12-31A$8.35 M-49.92%
2007-12-31A$16.69 M-44.86%
2006-12-31A$30.27 M-41.46%
2005-12-31A$51.72 M-28.67%
2004-12-31A$72.5 M55.4%
2003-12-31A$46.65 M-47.52%
2002-12-31A$88.89 M-28.1%
2001-12-31A$0.12 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
A$1.72 B-83.98%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.03 B-81.11%๐Ÿ‡บ๐Ÿ‡ธ USA
A$35.31 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
A$222.22 B 1,961.10%๐Ÿ‡ซ๐Ÿ‡ท France